For the Inventor, By the Inventor

Enter assignee name

Framingham, MA, United States of America

Genzyme Transgenics Corporation

USPTO Granted Patents = 12

Forward Citations = 463

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Harry M Meade (5 out of 22 patents)

Yann Echelard (3 out of 3 patents)

Edward S Cole (2 out of 6 patents)

4. Paul Ditullio (2 out of 6 patents)

5. Brian Wilburn (2 out of 2 patents)

6. Simon J Rothenberg (2 out of 2 patents)

7. Li-How Chen (1 out of 4 patents)

8. Daniel Pollock (1 out of 3 patents)

9. Paul DiTullio (1 out of 4 patents)

10. Li How Chen (1 out of 3 patents)

11. Ian Krane (1 out of 3 patents)

12. Michael Young (1 out of 2 patents)

13. David Melican (1 out of 1 patent)

14. Esmail Behbodi (1 out of 1 patent)

15. William Gavin (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 6593463 - Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems (2003-07-15),

2. 6580017 - Methods of reconstructed goat embryo transfer (2003-06-17),

3. 6548653 - Erythropoietin analog-human serum albumin fusion (2003-04-15),

4. 6545198 - Transgenically produced prolactin (2003-04-08),

5. 6528699 - Transgenically produced non-secreted proteins (2003-03-04),

6. 6441145 - Transgenically produced Antithrombin III (2002-08-27),

7. 6268487 - Purification of biologically active peptides from milk (2001-07-31),

8. 6210736 - Transgenically produced prolactin (2001-04-03),

9. 6073818 - Apparatus for controlled delivery of powdered solid materials (2000-06-13),

10. 5896829 - Head-only animal exposure chambers (1999-04-27),

11. 5849992 - Transgenic production of antibodies in milk (1998-12-15),

12. 5756687 - Isolation of components of interest from milk (1998-05-26),

Genzyme Transgenics Corporation is a biotechnology company specializing in the development and production of genetically engineered proteins for therapeutic use. With a focus on innovative research and cutting-edge technology, Genzyme Transgenics is dedicated to improving the lives of patients through the creation of novel biopharmaceuticals. Their commitment to quality and efficiency has made them a leader in the field of transgenic animal production and protein expression.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

12 Patents

#18 in Framingham, MA

#1,545 in Massachusetts

#25,526 in US

#48,090 in the World

Framingham, MA, United States of America

Genzyme Transgenics Corporation

Forward Citations = 463

25 inventors:

Harry M Meade (5 out of 22 patents)

Yann Echelard (3 out of 3 patents)

Edward S Cole (2 out of 6 patents)

4. Paul Ditullio (2 out of 6 patents)

5. Brian Wilburn (2 out of 2 patents)

Please report any incorrect information to [email protected]

Loading…